NCT06631859

Brief Summary

Thailand has entered an aging society, prompting increased research on improving the elderly quality of life and preventing age-related diseases, with a particular focus on skin aging. Skin aging is linked to the degradation of dermal and epidermal tissue, leading to decreased collagen, elastin, and glycosaminoglycans, which causes reduced skin elasticity and wrinkles. Assam tea is native to northern Thailand and is traditionally used in local products like fermented "Miang." Research shows that Assam tea contains high levels of polyphenols, particularly catechins, which have strong antioxidant properties that help combat conditions such as cancer, cardiovascular disease, and skin aging. The study aims to study the effect of cosmetic products from Assam tea on irritation, moisturization, skin elasticity, wrinkles, and satisfaction in volunteers to enhance its value, particularly for the elderly. This effort is intended to boost the local economy, promote community-based tourism, and expand Assam tea products to national and international markets, ultimately improving livelihoods and addressing environmental concerns in northern Thailand.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable healthy-volunteers

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

October 3, 2024

Last Update Submit

October 7, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Skin hydration

    Measure skin hydration by using a Corneometer®

    2 months

  • Transepidermal water loss (TEWL)

    Measure TEWL by using a Tewameter®

    2 months

  • Skin irritation

    Evaluate redness and edema occurred after applying the tested products by closed patch test under occlusion with Finn chamber®

    2 months

  • Values from Cutometer®

    Such as R0, R1, R2, R3, R4, R5, R6, R7, R8, R9

    2 months

  • Values from Skin-Visiometer®

    Such as Volume, Surface, SEr, SEsc, SEsm, SEw

    2 months

  • Sensory evaluation

    Measure the parameters such as color, odor, viscosity, texture, etc using labeled affective magnitude scale

    2 months

Study Arms (2)

Volunteers who recieved tested product

EXPERIMENTAL

Volunteers who recieved tested product

Other: Cosmetic products containing 2.5% Assam tea

Volunteers who recieved base product

PLACEBO COMPARATOR

Volunteers who recieved base product

Other: Cosmetic products containing 0% Assam tea

Interventions

Cosmetic products containing 0% Assam tea

Volunteers who recieved base product

Cosmetic products containing 2.5% Assam tea

Volunteers who recieved tested product

Eligibility Criteria

Age35 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 35 years and older
  • Good physical and mental health
  • Willing and able to provide informed consent to participate and complete the entire duration of the study

You may not qualify if:

  • Women who are pregnant or breastfeeding
  • Presence of existing dermatological conditions
  • History of autoimmune disorders
  • Prior use of products related to wrinkle reduction or those containing active ingredients that stimulate collagen or elastin production, including topical and oral products used within the past three months (e.g., coenzyme Q10, marine extracts, pine bark extract, glutathione, and vitamin C)
  • Participation in any other volunteer study or program within the past three months
  • Use of the following medications within the past three months: contraceptives, phenytoin, hydantoin, levodopa, chloroquine, cancer chemotherapy drugs, or medications containing heavy metals
  • History of receiving dermatological or cosmetic procedures such as IPL (Intense Pulse Light) laser, phonophoresis, iontophoresis, laser treatments, Botox injections, fillers, or stem cell injections
  • Volunteers who exhibit sensitivity or irritation to the test products used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Cosmetic Science, Mae Fah Luang University

Mueang, Changwat Chiang Rai, 57100, Thailand

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2024

First Posted

October 8, 2024

Study Start

March 17, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

October 8, 2024

Record last verified: 2024-10

Locations